Effect of paracetamol on blood pressure: A systematic review protocol

##plugins.themes.academic_pro.article.main##

Saoussen Miladi
Leila Rouached
Selma Bouden
Hiba Boussaa
Yasmine Makhlouf
Aicha Ben Tekaya
Ines Mahmoud
Rawdha Tekaya
Olfa Saidane
Kawther Ben Abdelghani
Alia Fazaa
Leila Abdelmoula
Ahmed Laatar

Abstract

Introduction: Paracetamol is widely used as a first-line treatment for chronic pain because it is thought to be safe. Unlike non-steroidal anti-inflammatory drugs (NSAIDs), paracetamol is thought to have no cardiovascular effects and specially no effect on blood pressure (BP). However, some studies suggest that paracetamol may increase BP. Thus, our aim was to address a systematic review in order to investigate the effects of regular paracetamol intake on BP.


Methods: To address this systematic review, a search on PubMed, Cochrane and Scopus is planned. A search on grey literature, registries, thesis and congress abstracts will be performed. We will include randomized clinical trials, interventional studies and observational studies. Studies on child bearing women and those with eclampsia or preeclampsia will be excluded. Besides, only studies using recommended dosage of paracetamol will be included. The primary outcomes of interest will be the change of BP before and after the intake of paracetamol. 


Discussion:   Change of BP will be assessed on patients taking paracetamol. Any previous cardiovascular disease or hypertension will be raised in order to identify if there are risk factors of hypertension under paracetamol. 

Keywords:

acetaminophen, hypertension, systolic blood pressure, diastolic blood pressure, adverse effect

##plugins.themes.academic_pro.article.details##

References

  1. (1) Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S. Paracetamol: new vistas of an old drug. CNS Drug Rev 2006;12:250-75.
  2. (2) Roberts E, Delgado Nunes V, Buckner S, Latchem S, Constanti M, Miller P, et al. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. 2015;75:552-9.
  3. (3) Chan AT, Manson JE, Albert CM, Chae CU, Rexrode KM, Curhan GC, et al. Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation. 2006;113:1578-87.
  4. (4) Forman JP, Stampfer MJ, Curhan GC. Non‐narcotic analgesic dose and risk of incident hypertension in US women. Hypertension. 2005;46:500-7.
  5. (5) Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
  6. (6) Turtle EJ, Dear JW, Webb DJ. A systematic review of the effect of paracetamol on blood pressure in hypertensive and non-hypertensive subjects. Br J Clin Pharmacol. 2013;75(6):1396-405.